HealthEdge Investment Partners announced that it has completed the sale of LifeSync, a developer, manufacturer, and marketer of disposable and reusable patient monitoring devices and connections sold to hospitals and other high acuity settings. LifeSync was acquired by Amphenol (APH).
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APH:
- Third Point buys Capital One, cuts Microsoft in Q4
- Amphenol Corporation’s Financial Stability Threatened by Market Volatility
- Amphenol Bolsters Market Position with Strategic Acquisitions
- Amphenol Corp’s Q4 2024 Earnings: Record Growth Amid Challenges
- Trump Trade: President blasts EU regulators for targeting U.S. tech companies